Zealand Pharma aktie (ZEAL) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Investeringsmöjlighet: Bli delägare i global ledare inom AI-baserad videoanalys på säkerhetsmarknaden (annons)

Pressmeddelanden från Zealand Pharma

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Zealand Pharma to participate in the Jefferies London Healthcare Conference

Zealand Pharma to participate in the Jefferies London Healthcare Conference

GlobeNewswire • 13 Nov 18:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 11 Nov 17:00

Zealand Pharma Announces Financial Results for the First Nine Months of 2024

Zealand Pharma Announces Financial Results for the First Nine Months of 2024

GlobeNewswire • 07 Nov 07:00

Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results

Zealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial results

GlobeNewswire • 01 Nov 17:30

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism

Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism

GlobeNewswire • 09 Oct 00:45

Zealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide

Zealand Pharma announces that Boehringer receives U.

GlobeNewswire • 08 Oct 08:40

Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024

Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024

GlobeNewswire • 30 Sep 17:00

Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th

Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th

GlobeNewswire • 13 Sep 17:01

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 12 Sep 17:01

Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide

Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dua...

GlobeNewswire • 09 Sep 17:01

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 30 Aug 22:00

Total number of shares and voting rights in Zealand Pharma on August 30, 2024

Total number of shares and voting rights in Zealand Pharma on August 30, 2024

GlobeNewswire • 30 Aug 17:00

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 22 Aug 22:00

Zealand Pharma major shareholder announcement: Bank of America Corporation

Zealand Pharma major shareholder announcement: Bank of America Corporation

GlobeNewswire • 16 Aug 18:05

Zealand Pharma Announces Financial Results for the First Half of 2024

Zealand Pharma Announces Financial Results for the First Half of 2024

GlobeNewswire • 15 Aug 07:00

Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results

Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results

GlobeNewswire • 12 Aug 17:00

Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

GlobeNewswire • 29 Jul 17:00

Zealand Pharma major shareholder announcement: Van Herk Investments

Zealand Pharma major shareholder announcement: Van Herk Investments

GlobeNewswire • 28 Jun 17:10

Total number of shares and voting rights in Zealand Pharma at June 28, 2024

Total number of shares and voting rights in Zealand Pharma at June 28, 2024

GlobeNewswire • 28 Jun 17:05

Zealand Pharma completes registration of capital increase

Zealand Pharma completes registration of capital increase

GlobeNewswire • 28 Jun 08:36

Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion

Zealand Pharma announces completion of an upsized equity offering of 8.

GlobeNewswire • 26 Jun 00:35

Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion

Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.

GlobeNewswire • 25 Jun 20:43

Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion

Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.

GlobeNewswire • 25 Jun 17:02

Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide

Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin a...

GlobeNewswire • 20 Jun 17:37

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 13 Jun 17:00

Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis

Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening o...

GlobeNewswire • 07 Jun 10:38

Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL

Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial with survodutide in MASH at EASL

GlobeNewswire • 06 Jun 12:29

Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency

Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Age...

GlobeNewswire • 31 May 16:03

Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024

Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024

GlobeNewswire • 29 May 17:10

Zealand Pharma major shareholder announcement: Polar Capital

Zealand Pharma major shareholder announcement: Polar Capital

GlobeNewswire • 29 May 13:32

Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide

Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agoni...

GlobeNewswire • 23 May 20:45

Zealand Pharma Announces Financial Results for the First Quarter of 2024

Zealand Pharma Announces Financial Results for the First Quarter of 2024

GlobeNewswire • 16 May 07:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 12 May 22:00

Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results

Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results

GlobeNewswire • 09 May 16:00

Correction to Company announcement – No. 23 / 2024

Correction to Company announcement – No.

GlobeNewswire • 19 Apr 22:20

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 19 Apr 17:05

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024

GlobeNewswire • 19 Apr 17:00

Total number of shares and voting rights in Zealand Pharma at March 31, 2024

Total number of shares and voting rights in Zealand Pharma at March 31, 2024

GlobeNewswire • 31 Mar 17:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 26 Mar 22:05

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 26 Mar 22:00

Zealand Pharma major shareholder announcement: Van Herk Investments

Zealand Pharma major shareholder announcement: Van Herk Investments

GlobeNewswire • 21 Mar 18:00

Zealand Pharma's Annual General Meeting 2024

Zealand Pharma's Annual General Meeting 2024

GlobeNewswire • 20 Mar 17:39

Zealand Pharma major shareholder announcement: Polar Capital

Zealand Pharma major shareholder announcement: Polar Capital

GlobeNewswire • 19 Mar 17:05

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 19 Mar 17:00

New Employee Elected Directors to the Board of Zealand Pharma A/S

New Employee Elected Directors to the Board of Zealand Pharma A/S

GlobeNewswire • 13 Mar 22:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 08 Mar 17:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 05 Mar 22:05

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 05 Mar 22:00

Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference

Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference

GlobeNewswire • 01 Mar 17:00

Zealand Pharma convenes its Annual General Meeting 2024

Zealand Pharma convenes its Annual General Meeting 2024

GlobeNewswire • 27 Feb 07:05

Zealand Pharma Announces Financial Results for the Full Year 2023

Zealand Pharma Announces Financial Results for the Full Year 2023

GlobeNewswire • 27 Feb 07:00

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver...

GlobeNewswire • 26 Feb 08:06

Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results

Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results

GlobeNewswire • 20 Feb 08:00

Total number of shares and voting rights in Zealand Pharma at January 31, 2024

Total number of shares and voting rights in Zealand Pharma at January 31, 2024

GlobeNewswire • 31 Jan 17:00

Zealand Pharma major shareholder announcement: Van Herk Investments

Zealand Pharma major shareholder announcement: Van Herk Investments

GlobeNewswire • 26 Jan 18:00

Zealand Pharma major shareholder announcement: J O Hambro Capital Management

Zealand Pharma major shareholder announcement: J O Hambro Capital Management

GlobeNewswire • 19 Jan 17:30

Zealand Pharma major shareholder announcement: J O Hambro Capital Management

Zealand Pharma major shareholder announcement: J O Hambro Capital Management

GlobeNewswire • 17 Jan 16:30

Zealand Pharma completes registration of capital increase

Zealand Pharma completes registration of capital increase

GlobeNewswire • 12 Jan 11:00

Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC

GlobeNewswire • 10 Jan 17:15

Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion

Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.

GlobeNewswire • 08 Jan 21:45

Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th

Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th

GlobeNewswire • 02 Jan 08:00

Total number of shares and voting rights in Zealand Pharma at December 29, 2023

Total number of shares and voting rights in Zealand Pharma at December 29, 2023

GlobeNewswire • 29 Dec 2023 17:00

U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of dosing due to inspection findings at third-party manufacturing facility

U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyperinsulinism for up to three weeks of do...

GlobeNewswire • 23 Dec 2023 10:47

Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome

Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome

GlobeNewswire • 22 Dec 2023 10:30

Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank

Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank

GlobeNewswire • 22 Dec 2023 08:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 07 Dec 2023 22:05

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 07 Dec 2023 22:00

Zealand Pharma to highlight obesity pipeline at R&D Event on December 5

Zealand Pharma to highlight obesity pipeline at R&D Event on December 5

GlobeNewswire • 04 Dec 2023 08:30

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 04 Dec 2023 08:00

Total number of shares and voting rights in Zealand Pharma at November 30, 2023

Total number of shares and voting rights in Zealand Pharma at November 30, 2023

GlobeNewswire • 30 Nov 2023 17:15

Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers

Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers

GlobeNewswire • 30 Nov 2023 08:00

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 16 Nov 2023 22:00

Zealand Pharma Announces Financial Results for the First Nine Months of 2023

Zealand Pharma Announces Financial Results for the First Nine Months of 2023

GlobeNewswire • 09 Nov 2023 07:00

Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023

Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023

GlobeNewswire • 07 Nov 2023 10:00

Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results

Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results

GlobeNewswire • 03 Nov 2023 17:00

Zealand Pharma major shareholder announcement: Polar Capital

Zealand Pharma major shareholder announcement: Polar Capital

GlobeNewswire • 20 Oct 2023 22:00

Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek

Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek

GlobeNewswire • 17 Oct 2023 08:00

Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease

Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular diseas...

GlobeNewswire • 05 Oct 2023 11:53

Total number of shares and voting rights in Zealand Pharma at September 29, 2023

Total number of shares and voting rights in Zealand Pharma at September 29, 2023

GlobeNewswire • 29 Sep 2023 17:15

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 14 Sep 2023 22:30

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 14 Sep 2023 22:00

SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023

SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023

GlobeNewswire • 08 Sep 2023 11:00

Zealand Pharma to participate in upcoming healthcare conferences in September 2023

Zealand Pharma to participate in upcoming healthcare conferences in September 2023

GlobeNewswire • 07 Sep 2023 17:00

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 31 Aug 2023 17:35

Total number of shares and voting rights in Zealand Pharma at August 31, 2023

Total number of shares and voting rights in Zealand Pharma at August 31, 2023

GlobeNewswire • 31 Aug 2023 17:30

Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism

Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism

GlobeNewswire • 30 Aug 2023 07:33

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 25 Aug 2023 16:45

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 24 Aug 2023 22:00

Zealand Pharma Announces Financial Results for the First Half of 2023

Zealand Pharma Announces Financial Results for the First Half of 2023

GlobeNewswire • 17 Aug 2023 07:00

Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results

Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results

GlobeNewswire • 14 Aug 2023 17:05

Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396

Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396

GlobeNewswire • 03 Jul 2023 12:01

Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism

Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism

GlobeNewswire • 30 Jun 2023 19:32

Total number of shares and voting rights in Zealand Pharma at June 30, 2023

Total number of shares and voting rights in Zealand Pharma at June 30, 2023

GlobeNewswire • 30 Jun 2023 17:05

Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency

Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European...

GlobeNewswire • 26 Jun 2023 08:30

Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions

Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions

GlobeNewswire • 24 Jun 2023 17:35

Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)

Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survod...

GlobeNewswire • 23 Jun 2023 23:15

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire • 08 Jun 2023 22:00

Zealand Pharma to Participate in Upcoming Healthcare Conferences

Zealand Pharma to Participate in Upcoming Healthcare Conferences

GlobeNewswire • 06 Jun 2023 17:00

Total number of shares and voting rights in Zealand Pharma at May 31, 2023

Total number of shares and voting rights in Zealand Pharma at May 31, 2023

GlobeNewswire • 31 May 2023 17:05

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely asso...

GlobeNewswire • 25 May 2023 22:00